Reblozyl
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.reblozyl.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Reblozyl
Bristol Myers Squibb offers REBLOZYL® (luspatercept-aamt), a prescription medicine specifically designed to treat anemia in adults suffering from myelodysplastic syndromes (MDS) and beta thalassemia (BT). The medication is intended for patients who require regular red blood cell transfusions and have not responded to or cannot use previous erythropoiesis stimulating agents. REBLOZYL® is administered via subcutaneous injection and aims to increase hemoglobin levels in these patients. The company also provides extensive support resources for healthcare professionals and patients regarding the use and effects of REBLOZYL®.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Reblozyl your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Reblozyl, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Reblozyl launches new products
Website visits: Recent activity has been detected on your website
Check out if Reblozyl is spiking on competitors!
Click to see if Reblozyl had a recent Job posting/layoffs
Earning: See what the market has to say on Reblozyl recently announced quarterly report
Funding: Get notified immidiatlly once Reblozyl has new funding data
Check if Reblozyl has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Reblozyl
Recommended Actions
Reach out to Masked Content who joined Reblozyl as Masked Content
Find 2 more new buyers
Compare Similar Companies to Reblozyl
Compare insights from companies similar to Reblozyl, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Reblozyl is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Reblozyl is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Reblozyl.
Reblozyl Tech Stack
A closer look at the technologies used by Reblozyl
Reblozyl News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Reblozyl
Sign Up For FreeTo access detailed company insights
Bristol Myers Squibb offers REBLOZYL® (luspatercept-aamt), a prescription medicine specifically designed to treat anemia in adults suffering from myelodysplastic syndromes (MDS) and beta thalassemia (BT). The medication is intended for patients who require regular red blood cell transfusions and have not responded to or cannot use previous erythrop... Read More
